http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I633118-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b89836578cc7473ba52a75734623004b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-805 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-805 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2015-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95c547ce908d04cd61a639c71a414f4f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d1825e15e577fb3f53a9107272fc0b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04ab6df4d4e2a88d2e0958595ee00f77 |
| publicationDate | 2018-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I633118-B |
| titleOfInvention | Medicinal composition comprising a recombinant hemoglobin-based or subunit-based therapeutic agent for cancer target treatment |
| abstract | The invention provides a pharmaceutical composition containing recombinant heme protein, tetramer, dimer or subunit, which is used for tissue oxygenation and cancer treatment. The therapeutic agent based on recombinant hemoglobin or tetramer or dimer or subunit is also effective for the treatment of cancer. Recombinant heme or tetramer or dimer or its subunit portion can target cancer cells, and the therapeutic portion (ie, active agent / therapeutic drug) can effectively kill these cancer cells. The therapeutic agent based on recombinant heme or tetramer or dimer or its subunit used in the present invention can be used to treat various cancers, such as pancreatic cancer, leukemia, head and neck cancer, colorectal cancer, lung cancer, breast cancer, liver cancer, nose Pharyngeal cancer, esophageal cancer, prostate cancer, stomach cancer and brain cancer. The composition can be used alone or in combination with other therapeutic agents such as chemotherapeutic agents, radiotherapy agents, anti-cancer protein drugs to provide a synergistic effect on cancer treatment, inhibit cancer metastasis and / or reduce recurrence. |
| priorityDate | 2014-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 273.